A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Kidney Cancer
Related studies linked through entity extraction aliases.
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
- Status
- TERMINATED
- Phase
- PHASE2
Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
- Status
- TERMINATED
- Phase
- PHASE3
Bupropion in Helping Adults Stop Smoking
- Status
- COMPLETED
- Phase
- PHASE2
Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Biobehavioral Effects of Emotional Expression in Cancer
- Status
- COMPLETED
- Phase
- NA
Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronate With Atorvastatin in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Talabostat in Treating Patients With Metastatic Kidney Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2